1
/
of
1
Apixero (Apixaban)
Apixero (Apixaban)
Regular price
₱2,150.00 PHP
Regular price
Sale price
₱2,150.00 PHP
Unit price
₱71.67 each
Taxes included.
Quantity
Couldn't load pickup availability
Apixaban, commonly marketed as Apixero, is a prescription oral anticoagulant medication designed to prevent and treat blood clots effectively. As a direct Factor Xa inhibitor, apixaban works by selectively blocking Factor Xa, a critical clotting protein in the bloodstream, thereby reducing thrombin production and preventing the formation of dangerous fibrin clots.
Apixaban is widely prescribed for multiple cardiovascular and thromboembolic conditions. It is highly effective for stroke prevention in patients with non-valvular atrial fibrillation, a common heart rhythm disorder. Additionally, it is used for the treatment and secondary prevention of deep vein thrombosis (DVT), a condition involving blood clots in the deep veins of the legs, and pulmonary embolism (PE), where blood clots travel to the lungs. Apixaban is also recommended for patients recovering from major orthopedic surgeries, such as hip and knee replacement procedures, to reduce postoperative clotting complications.
What sets apixaban apart from traditional anticoagulants like warfarin is its superior pharmacological profile. It offers predictable and consistent dosing without requiring routine blood monitoring, provides fewer drug-food interactions, and demonstrates a favorable safety record with a lower incidence of major bleeding events in many clinical populations. These characteristics make apixaban a preferred choice among healthcare providers and patients alike.
Typical dosing varies by indication. For atrial fibrillation, the standard dose is 5 mg taken twice daily. For prevention of thromboembolism following joint replacement surgery, the dose is typically 2.5 mg taken twice daily. Individual dosing adjustments may be necessary based on age, weight, renal function, and other patient-specific factors, and should always be determined by a qualified healthcare provider.
Apixaban is recommended by major international clinical guidelines for long-term anticoagulation therapy due to its proven efficacy, favorable safety profile, patient convenience, and ease of administration. Consult with your healthcare provider or pharmacist for personalized prescribing information and dosage adjustments appropriate for your specific medical condition and circumstances.
Apixaban is widely prescribed for multiple cardiovascular and thromboembolic conditions. It is highly effective for stroke prevention in patients with non-valvular atrial fibrillation, a common heart rhythm disorder. Additionally, it is used for the treatment and secondary prevention of deep vein thrombosis (DVT), a condition involving blood clots in the deep veins of the legs, and pulmonary embolism (PE), where blood clots travel to the lungs. Apixaban is also recommended for patients recovering from major orthopedic surgeries, such as hip and knee replacement procedures, to reduce postoperative clotting complications.
What sets apixaban apart from traditional anticoagulants like warfarin is its superior pharmacological profile. It offers predictable and consistent dosing without requiring routine blood monitoring, provides fewer drug-food interactions, and demonstrates a favorable safety record with a lower incidence of major bleeding events in many clinical populations. These characteristics make apixaban a preferred choice among healthcare providers and patients alike.
Typical dosing varies by indication. For atrial fibrillation, the standard dose is 5 mg taken twice daily. For prevention of thromboembolism following joint replacement surgery, the dose is typically 2.5 mg taken twice daily. Individual dosing adjustments may be necessary based on age, weight, renal function, and other patient-specific factors, and should always be determined by a qualified healthcare provider.
Apixaban is recommended by major international clinical guidelines for long-term anticoagulation therapy due to its proven efficacy, favorable safety profile, patient convenience, and ease of administration. Consult with your healthcare provider or pharmacist for personalized prescribing information and dosage adjustments appropriate for your specific medical condition and circumstances.
Share
